Phase II study of high-dose cisplatin, e
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer
β
J.M. Cain; C. Collins; S. Petersdorf; D.C. Figge; H.K. Tamimi; B.E. Greer; R.B.
π
Article
π
1996
π
Elsevier Science
π
English
β 688 KB